ETC

Recommend
Index
  • Depakine Chrono Tab. 500mg

    Depakine Chrono Tab. 500mg

    Ingredient

    Sodium Valproate/Valproic Acid

    Content

    500mg

    Indication

    1) Prevention and treatment of epilepsy (absence seizure, tonic-clonic seizure, clonic seizures, psychomotor seizure, and mixed seizure) and personality disorder or behavioral disorder followed by epilepsy
    2) Treatment of manic episodes associated with bipolar disorder
    -In regard to manic episodes, safety and efficacy of this drug are not established for long-term use of 3 weeks or more. Therefore, a regular drug re-evaluation is needed for long-term drug use.

  • Dermatop Ointment/Cream/Soln. 0.25%

    Dermatop Ointment/Cream/Soln. 0.25%

    Ingredient

    Prednicarbate

    Content

    2.5mg/g (Ointment and Cream), 0.25mg/100g (Solution)

    Indication

    Treatment of corticosteroid reactive dermatoses: Eczema, dermatitis (atopic dermatitis, seborrheic dermatitis, allergic contact dermatitis, parapsoriasis, lichen planus, prurigo), and psoriasis

  • Esperson Gel 0.05%

    Esperson Gel 0.05%

    Ingredient

    Desoxymethasone

    Content

    0.5mg/g

    Indication

    Treatment of corticosteroid reactive dermatoses: Contact dermatitis, nummular eczema, lichen simplex chronicus (neurodermatitis), discoid erythema, atopic dermatitis, seborrheic dermatitis, psoriasis, insect bites, acute vesiculobullous hand eczema, prurigo, and intertrigo

  • Esperson Lotion 0.25%

    Esperson Lotion 0.25%

    Ingredient

    Desoxymethasone

    Content

    2.5mg/g

    Indication

    Treatment of corticosteroid reactive dermatoses: Contact dermatitis, nummular eczema, lichen simplex chronicus (neurodermatitis), discoid erythema, atopic dermatitis, seborrheic dermatitis, psoriasis, insect bites, acute vesiculobullous hand eczema, prurigo, and intertrigo

  • Fraxiparine Inj. (Pre-filled)

    Fraxiparine Inj. (Pre-filled)

    Ingredient

    Nadroparin Calcium

    Content

    2850IU/0.3ml, 5700IU/0.6ml

    Indication

    1) Prophylaxis of thromboembolism, especially the prophylaxis of thromboembolism accompanying orthopedic surgery and general surgery
    2) Treatment of deep vein thrombosis (DVT)
    3) Prevention of clotting in extracorporeal circulation during hemodialysis
    4) Treatment of unstable angina and non-Q wave myocardial infarction

  • Galafold Cap.

    Galafold Cap.

    Ingredient

    Migalastat Hydrochloride

    Content

    150mg (123mg as Migalastat)

    Indication

    Long-term treatment of patients aged 12 years and older with a confirmed diagnosis of Fabry disease (α-galactosidase A deficiency) and who have an amenable mutation

  • IMOJEV® Japanese encephalitis vaccine (live, attenuated)

    IMOJEV® Japanese encephalitis vaccine (live, attenuated)

    Ingredient

    Live, attenuated, recombinant Japanese encephalitis virus*: 4.0 – 5.8 log PFU

    Content
    Indication

    prophylaxis of Japanese encephalitis caused by the Japanese
    encephalitis virus, in persons from 9 months of age and over.

  • Ketas Cap. 10mg

    Ketas Cap. 10mg

    Ingredient

    Ibudilast Granule

    Content

    190mg (10mg as Ibudilast)

    Indication

    Treatment of post stroke dizziness in patients with chronic cerebral circulation disorder associated with a previous cerebral infarction

  • Lasix Inj.

    Lasix Inj.

    Ingredient

    Furosemide

    Content

    20mg/2ml

    Indication

    1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; acute pulmonary edema
    2) Management of essential or renal hypertension

  • Lasix Tab.

    Lasix Tab.

    Ingredient

    Furosemide

    Content

    40mg

    Indication

    Treatment of essential or renal hypertension; cardiac (congestive heart failure), renal, hepatic (ascites) and peripheral vascular edema

TOP